jazz pharmaceuticals plc
(JAZZ:NASDAQ GS)

Executive Profile*

Background*

Mr. Bruce C. Cozadd has been an Executive Chairman and Chief Executive Officer of Jazz Pharmaceuticals plc since January 2012. Mr. Cozadd serves as the Chairman and Chief Executive Officer at Azur Pharma Limited. He co-founded Jazz Pharmaceuticals, Inc. in 2003 and has been its Chairman and Chief Executive Officer since April 2009. He served in various executive management positions with ALZA Corporation from 1991 to 2001, including Vice President of Corporate Planning ... and Analysis. He served as Executive Vice President and Chief Operating Officer of ALZA Corporation from January 2000 to 2001. He served as Senior Vice President of ALZA from 1997 to 1999, Chief Financial Officer from 1994 to 1999 and Vice President from 1994 to 1996. Mr. Cozadd served as an Executive Chairman of Jazz Pharmaceuticals, Inc. from 2003 to 2009. Mr. Cozadd has been a Director of Cerus Corporation since November 2001, Jazz Pharmaceuticals, Inc. since 2003, Threshold Pharmaceuticals Inc. since December 27, 2005 and Danisco US Inc. since 2000. He serves as a Director of EKOS Corporation. He serves on the boards of The Nueva School, Stanford Hospital and Clinics and the Stanford Molecular Imaging Advisory Board. He served as a Member of the Health Care Investment Banking team at Smith Barney, Harris Upham & Co. Mr. Cozadd received an MBA from the Stanford Graduate School of Business and a B.A. in Molecular Biophysics and Biochemistry and Economics from Yale University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
JAZZ:US	$63.75 USD	+0.75

COMPETITOR COMPENSATION